ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
csrwin
|
265 |
105K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
105K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
csrwin
|
265 |
105K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
105K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
csrwin
|
265 |
105K |
0 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
105K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
csrwin
|
265 |
105K |
2 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
105K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
csrwin
|
265 |
105K |
4 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
105K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
csrwin
|
265 |
105K |
1 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
265
|
105K
|
1
|
|
Charts
|
ACW |
Re:
ACW Chart Thread
|
|
csrwin
|
138 |
56K |
10 |
08/07/24 |
08/07/24 |
Charts
|
138
|
56K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
csrwin
|
943 |
406K |
0 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
943
|
406K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
csrwin
|
18K |
6.9M |
2 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
18K
|
6.9M
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Holy grail found
|
|
csrwin
|
88 |
39K |
6 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
88
|
39K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
csrwin
|
5.7K |
2.8M |
0 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
5.7K
|
2.8M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to File BLA for Ryoncil FDA Approval Next Week
|
|
csrwin
|
181 |
79K |
2 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
181
|
79K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
csrwin
|
943 |
406K |
1 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
943
|
406K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
csrwin
|
1.0K |
438K |
1 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
1.0K
|
438K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
csrwin
|
1.0K |
438K |
0 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
1.0K
|
438K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to File BLA for Ryoncil FDA Approval Next Week
|
|
csrwin
|
181 |
79K |
0 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
181
|
79K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
2 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
csrwin
|
88 |
32K |
1 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
88
|
32K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
csrwin
|
943 |
406K |
10 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
943
|
406K
|
10
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
csrwin
|
88 |
32K |
6 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
88
|
32K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
csrwin
|
943 |
406K |
17 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
943
|
406K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
1 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
10K
|
3.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
2 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
10K
|
3.3M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
14 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
10K
|
3.3M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
29 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
10K
|
3.3M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
csrwin
|
943 |
406K |
14 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
943
|
406K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
0 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
10K
|
3.3M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
0 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
10K
|
3.3M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
csrwin
|
1.0K |
438K |
8 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
1.0K
|
438K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
csrwin
|
675 |
304K |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
675
|
304K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen announces capital raising of up to $8.9 million
|
|
csrwin
|
40 |
12K |
7 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
40
|
12K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
csrwin
|
1.0K |
438K |
2 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
1.0K
|
438K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
csrwin
|
245 |
69K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
245
|
69K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
csrwin
|
1.0K |
438K |
10 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
1.0K
|
438K
|
10
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW Clinical Trials Science Forum 23 May registration detail
|
|
csrwin
|
2 |
1.1K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
2
|
1.1K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW March 2024 quarterly activity report & Appendix 4C
|
|
csrwin
|
38 |
11K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
38
|
11K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
csrwin
|
671 |
244K |
1 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
671
|
244K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Change in substantial holding
|
|
csrwin
|
5 |
1.4K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
5
|
1.4K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
csrwin
|
245 |
69K |
1 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
245
|
69K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
csrwin
|
245 |
69K |
0 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
245
|
69K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
csrwin
|
245 |
69K |
1 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
245
|
69K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
csrwin
|
245 |
69K |
0 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
245
|
69K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
csrwin
|
18K |
6.9M |
21 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
18K
|
6.9M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
csrwin
|
18K |
6.9M |
8 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
18K
|
6.9M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
csrwin
|
671 |
244K |
1 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
671
|
244K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Valuation
|
|
csrwin
|
92 |
54K |
4 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
92
|
54K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
csrwin
|
671 |
244K |
3 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
671
|
244K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
csrwin
|
671 |
244K |
4 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
671
|
244K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
csrwin
|
671 |
244K |
12 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
671
|
244K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
csrwin
|
671 |
244K |
3 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
671
|
244K
|
3
|
|